Longevity GlycanAge closes $8.7m to take glycan biomarkers into hospitalsBy adminDecember 20, 20250 Funding accelerates clinical rollout of glycan biomarkers for aging and inflammation, pushing them into mainstream preventive care. GlycanAge, a London-based…
